InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
10
Disclosed sells
0
T+90 hit rate
14%
T+90 mean return
-29.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Young David, Chief Executive Officer. Insider active across 1 company, notably Processa Pharmaceuticals, Inc.. In total, 20 filings have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €315k. Activity tracked since 23 June 2021. The latest transaction was filed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Young David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,706 shares@ US$2.690.077% mcap0.8% of flowCommon StockSEC:0000897069-26-001010:0
Canonical exit: 29 Jul 2026 (T+90)
1,545 shares@ US$2.970.076% mcap0.8% of flowCommon StockSEC:0000897069-26-000912:0
Canonical exit: 14 Jul 2026 (T+90)
1,810 shares@ US$2.5351.0% of flowCommon StockSEC:0000897069-26-000756:0
Canonical exit: 29 Jun 2026 (T+90)
49 shares0Common StockSEC:0000897069-26-000224:0
17,272 sharesCommon StockSEC:0000897069-25-000787:0
124,500 shares@ US$0.797520.8% of flowCommon StockSEC:0000897069-25-000132:0
Canonical exit: 27 Apr 2025 (T+90)
1,675 sharesCommon StockSEC:0000897069-24-001606:0
1,675 sharesCommon StockSEC:0000897069-24-000925:0
21,000 shares@ US$2.453610.5% of flowCommon StockSEC:0000897069-24-000269:0
Canonical exit: 7 May 2024 (T+90)
20,000 shares@ US$2.525210.3% of flowCommon StockSEC:0000897069-24-000253:0
Canonical exit: 6 May 2024 (T+90)
155,277 shares@ US$0.299.4% of flowCommon StockSEC:0000897069-23-001460:0
142,000 shares@ US$0.247.0% of flowCommon StockSEC:0000897069-23-001444:0
40,000 shares@ US$0.806.5% of flowCommon StockSEC:0000897069-23-000716:0
Canonical exit: 10 Sept 2023 (T+90)
20,000 shares@ US$0.54992.2% of flowCommon StockSEC:0000897069-23-000278:0
Canonical exit: 13 Jul 2023 (T+90)
20,000 shares@ US$0.522.1% of flowCommon StockSEC:0000897069-23-000269:0
Canonical exit: 10 Jul 2023 (T+90)
18,750 shares@ US$0.803.1% of flowCommon StockSEC:0001567619-23-002398:0
9,250 shares0Common StockSEC:0001567619-22-016597:0
7,601 sharesCommon StockSEC:0001567619-22-015306:0
7,601 sharesCommon StockSEC:0001567619-21-014741:0
10,000 shares@ US$7.671615.9% of flowCommon StockSEC:0001567619-21-012540:0
Canonical exit: 21 Sept 2021 (T+90)
20 of 20 declarations
About Young David
Young David is Directeur Général and is listed as Pres. Research & Development at Processa Pharmaceuticals, Inc. Across 20 total filings, the 20 most recent sampled filings cover acquisitions from 2021-06-23 to 2026-05-01, with EUR 315025 of buys and EUR 0 of sells.
